Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential thrombocythaemia and peripheral gangrene.

F E Preston, I G Emmanuel, D A Winfield

    British Medical Journal
    |August 31, 1974
    PubMed
    Summary

    Essential thrombocythaemia, a blood disorder, can cause toe gangrene. Aspirin relieved pain and improved platelet aggregation, while phosphorus-32 treatment prevented recurrence, highlighting essential thrombocythaemia as a treatable cause of vascular disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Guidelines on the diagnosis and management of chronic liver disease in haemophilia.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Development of a World Federation of Hemophilia External Quality Assessment Scheme: results of a pilot study.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Stability of coagulation proteins in lyophilized plasma.

    International journal of laboratory hematology·2014
    Same author

    Importance of Night-vision Tests.

    British medical journal·2010
    Same author

    Quality issues in laboratory haemostasis.

    Haemophilia : the official journal of the World Federation of Hemophilia·2010
    Same author

    Mass in Vitreous in a Boy aged 5, ? Glioma.

    Proceedings of the Royal Society of Medicine·2009

    Area of Science:

    • Hematology
    • Vascular Medicine
    • Oncology

    Background:

    • Essential thrombocythaemia (ET) is a myeloproliferative neoplasm characterized by elevated platelet counts.
    • Peripheral vascular disease (PVD) can manifest as a presenting symptom of ET, leading to critical limb ischemia.
    • Understanding the link between ET and PVD is crucial for timely diagnosis and effective management.

    Purpose of the Study:

    • To investigate the association between essential thrombocythaemia and peripheral vascular disease.
    • To evaluate the efficacy of aspirin and phosphorus-32 in managing ET-related PVD.
    • To analyze platelet aggregation patterns in patients with ET and PVD.

    Main Methods:

    • Case series describing six patients with toe gangrene as the initial symptom of ET.

    Related Experiment Videos

  • Platelet-rich plasma analysis to assess spontaneous and induced platelet aggregation (using adenosine diphosphate and collagen).
  • Evaluation of treatment response to aspirin and phosphorus-32, including PVD recurrence and platelet function tests.

    • Main Results:

    • All six patients presented with toe gangrene attributed to ET.
    • Abnormal spontaneous and induced platelet aggregation was observed in all patients.
    • Aspirin ingestion led to rapid pain relief and normalization of platelet aggregation.
    • Phosphorus-32 treatment normalized platelet counts and prevented further PVD events.
    • Platelet function tests normalized after treatment.

    Conclusions:

    • Essential thrombocythaemia is a significant and treatable cause of peripheral vascular disease.
    • Aspirin demonstrates rapid efficacy in alleviating symptoms and correcting platelet dysfunction in ET-related PVD.
    • Long-term management with agents like phosphorus-32 can prevent recurrence of vascular complications in ET.